Skip to Main Content
Justin Jordan, M.D.,  M.P.H.

Justin Jordan, M.D., M.P.H.

Titles and Appointments

Associate Professor

School
Medical School
Department
Neurology | Peter O'Donnell Jr. Brain Institute

You have reached the Academic Profile.

For more information on the doctor and patient care, please visit the clinical profile.

  • Biography

    Dr. Jordan is Associate Professor of Neurology with a secondary appointment in the Peter O’Donnell Jr. Brain Institute at the University of Texas Southwestern Medical Center in Dallas, Texas. He serves as Head of the Neuro-Oncology Section, where he treats patients with primary brain tumors and also runs a comprehensive clinic for adult patients affected by NF1 and schwannomatosis. Dr. Jordan also has a long history of conducting research related to NF1 and schwannomatosis, including work on interventional clinical trials for cutaneous neurofibromas, plexiform neurofibromas, and gliomas in NF1, all tumor types in NF2-related schwannomatosis, and chronic pain in non-NF2-related schwannomatosis. He has collaborated or led research investigations on novel imaging techniques including longitudinal whole body MRI scans, radiomics, and high-frequency ultrasound to advance our understanding of tumor behavior over time. He is a member of the Clinical Care Advisory Board of the Children's Tumor Foundation, and served as Chair of the Scientific Advisory Committee for Neurofibromatosis Network 2022-2025.

    Dr. Jordan is also deeply committed to promoting data-driven improvements in the healthcare landscape. She serves as Head of the Policy, Outreach, and Societal Transformation (POST) Section in the Department of Neurology, with focused work on health policy, community-based neurology care, and global neurology care. He is also Vice Chair of the Advocacy Committee and a Member of the Brain Health Committee within the American Academy of Neurology.

  • Education
    Medical School
    McGovern Medical School at the University of Texas Health Science Center at Houston (2009)
    Residency
    Parkland Health & Hospital System (2013), Neurology
    Fellowship
    Harvard Medical School/Massachusetts General Hospital (2015), Neuro-oncology
  • Research Interest
    • Brain Tumors
    • Glioblastoma
    • IDH mutant gliomas
    • Neurofibromatosis
    • NF2-related schwannomatosis
    • Schwannomatosis
  • Publications
    A single-cell atlas of Schwannoma across genetic backgrounds and anatomic locations
    Gonzalez Castro LN, Gavish A, Bussema L, Mount CW, Neftel C, Nomura M, Chiocca EA, Bi WL, Arnaout O, Barker FG, Brown JM, Jordan JT, Batchelor TT, Stemmer-Rachamimov A, Plotkin SR, Tirosh I, Suvà ML Genome Medicine 2025 Dec 17
    Self-reported access to specialty clinics and receipt of health surveillance among U.S. patients with neurofibromatosis 1: a national survey
    Merker VL, Ma Y, Chibnik LB, Radtke HB, Kelts K, Yohay K, Ullrich NJ, Plotkin SR, Jordan JT Orphanet Journal of Rare Diseases 2025 Dec 20
    Principles for Novel Neurologic Therapeutics: An AAN Position Statement
    Goldstein LB, Crowe JR, Deb A, Jordan JT, Santoro JD, Sejvar JJ, Turbes M, Shapiro RE Neurology 2025 Jun 105
    Bridging the Gap Between Brain Health Guidelines and Real-world Implementation
    Correa DJ, Jordan JT, Said RR CONTINUUM Lifelong Learning in Neurology 2025 Jun 31 865-884
    ACR Appropriateness Criteria® Brain Tumors
    Author Collaboration EP, Ivanidze J, Shih RY, Utukuri PS, Ajam AA, Auron M, Chang SM, Jordan JT, Kalnins A, Kuo PH, Ledbetter LN, Pannell JS, Pollock JM, Sheehan J, Soares BP, Soderlund KA, Wang LL, Burns J Journal of the American College of Radiology 2025 May 22 S108-S135
    AAN Position: Opioids
    Najib U, Cheng EM, Halker Singh RB, Ayub N, Nelson SE, Bushard PJ, Jordan JT, Sico JJ, Turbes M, Anderson WE Neurology 2025 Apr 104
    Ivosidenib for the treatment of IDH1-mutant glioma, grades 2-4: Tolerability, predictors of response, and outcomes
    Lanman TA, Youssef G, Huang R, Rahman R, Desalvo M, Flood T, Hassanzadeh E, Lang M, Lauer J, Potter C, Jiao A, Pan I, Cahill DP, Lan Z, Ospina JP, Nakhate V, Stec NE, Shi D, Bi WL, McBrayer SK, Arrillaga-Romany I, Lee EQ, Chukwueke UN, Nayak L, Forst DA, Gerstner ER, Jordan JT, Dietrich J, Miller J, Batchelor TT, Reardon DA, Wen PY, Gonzalez Castro LN Neuro-Oncology Advances 2025 Jan 7
    Increased Hemorrhage During Excision of Bevacizumab-Treated NF2-Related Vestibular Schwannomas
    Wood CG, Kozanno L, Stemmer-Rachamimov A, Lee DJ, Barker FG, Carter BS, Plotkin SR, Jordan JT, Chang LS, Welling DB Laryngoscope 2025
    Reply to L. Lucchino et al. on commentary on “Histologic correlates of “Choroidal Abnormalities” in Neurofibromatosis type 1”
    Stemmer-Rachamimov AO, Kozanno L, Plotkin SR, Jordan JT, Rizzo JF Acta Neuropathologica 2024 Dec 148
    Rapid tumor DNA analysis of cerebrospinal fluid accelerates treatment of central nervous system lymphoma
    Gupta M, Bradley JD, Massaad E, Burns EJ, Georgantas NZ, Maron GE, Batten JM, Gallagher A, Thierauf J, Nayyar N, Gordon A, Jones SA, Pisapia M, Sun Y, Jones PS, Barker FG, Curry WT, Gupta R, Romero JM, Wang N, Brastianos PK, Martinez-Lage M, Tateishi K, Forst DA, Nahed BV, Batchelor TT, Ritterhouse LL, Iser F, Kessler T, Jordan JT, Dietrich J, Meyerson M, Cahill DP, Lennerz JK, Carter BS, Shankar GM Blood 2024 Sep 144 1093-1100
  • Books

    Featured 

  • Honors & Awards
    • Make NF Visible Community Recognition Award Nominee
      Children's Tumor Foundation (2024)
    • Top Reviewer Reward
      Neurology: Education journal (2022)
    • Patient Safety Stars Award
      Massachusetts General Hospital (2021)
    • Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) Scholar
      REiNS (2016)
    • Distinguished Alumnus Lecturer
      UT Southwestern Medical Center, Department of Neurology (2015)
    • Ether Dome Challenge Award
      Mass General Cancer Center
  • Professional Associations/Affiliations
    • American Academy of Neurology
    • Children's Tumor Foundation
    • Society for Neuro-Oncology